# Sanofi

> Sanofi is a VC fund in Mumbai backing Medical, Internet and Biopharma. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Mumbai, India
- Total investments: 3
- Last investment: Sep 2024
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/sanofi-india-ltd/
- Website: https://www.sanofiindialtd.com/

Sanofi is a VC fund in Mumbai focused on Medical and Internet. They, at Sanofi, are there beside people to support them during their health challenges. We aim to prevent illnesses through our vaccines, provide innovative treatments to fight pain and ease suffering.They stand by the few who suffer from rare diseases and millions with long-term chronic conditions.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Internet | 1 | 33% |
| Biopharma | 1 | 33% |
| Biotechnology | 1 | 33% |
| Manufacturing | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Pre-Seed | 1 | 33% |
| Post-IPO Equity | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 1 | 33% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ventyx Biosciences | Ventyx Biosciences is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Ventyx’s clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1 peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. | $27M | Post-IPO Equity | Sep 23, 2024 |  |
| SiCureMi | SiCureMi is a medical device manufacturing company that specializes in the fields of vital signs monitoring and decision support. It aims to develop an affordable and non-invasive intelligent self-care product for users providing personalized care using predictive analytics from historical/real-time data using IOT/Mobile based app. | $425K | Pre-Seed | Sep 22, 2021 |  |
| SiCureMi | SiCureMi is a medical device manufacturing company that specializes in the fields of vital signs monitoring and decision support. It aims to develop an affordable and non-invasive intelligent self-care product for users providing personalized care using predictive analytics from historical/real-time data using IOT/Mobile based app. | $750K | Seed | Sep 22, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Biotechnology Industry Research Assistance Council(BIRAC)](https://shizune.co/investors/profile/biotechnology-industry-research-assistance-council-birac) — VC Fund, 2 deals together
- [Centre for Cellular and Molecular Platforms](https://shizune.co/investors/profile/centre-for-cellular-and-molecular-platforms) — VC Fund, 2 deals together
- [COPIC Companies](https://shizune.co/investors/profile/copic-companies) — VC Fund, 2 deals together
- [Pfizer](https://shizune.co/investors/profile/pfizer-d00f) — VC Fund, 2 deals together
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Medical Investors in India](https://shizune.co/investors/medical-investors-india)
- [Medical VC Funds in India](https://shizune.co/investors/medical-vc-funds-india)

## FAQ

### What does Sanofi invest in?

Sanofi invests primarily in Medical, Internet and Biopharma startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sanofi last invest?

The most recent investment recorded for Sanofi closed in Sep 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co